Filter
480
Filtered Results: 480
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
67
New Publications
100
Language
Document type
No document type
218
Guidelines
126
Studies & Reports
57
Manuals
43
Fact sheets
14
Strategic & Response Plan
13
Training Material
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
24
Germany
15
Global
12
South Africa
11
Latin America and the Carribbean
11
Africa
10
Western and Central Europe
8
Russia
7
Ethiopia
5
Kenya
5
Tanzania
5
Rwanda
5
Nigeria
4
Cameroon
4
Namibia
4
Brazil
4
Eastern Europe
4
Burkina Faso
3
Uganda
3
Zambia
3
West and Central Africa
3
Congo-Brazzaville
3
Sierra Leone
2
Senegal
2
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Haiti
2
Nepal
2
Bangladesh
2
Malawi
2
Benin
2
Argentina
2
Eswatini/ Swaziland
2
Ukraine
2
Madagascar
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Asia
2
Venezuela
2
France
2
Guinea
1
Liberia
1
USA
1
Togo
1
Zimbabwe
1
Philippines
1
South Sudan
1
Turkey
1
Syria
1
Gambia
1
Indonesia
1
Peru
1
Burundi
1
Colombia
1
Bolivia
1
Angola
1
Chile
1
Yemen
1
South–East Asia Region
1
Luxembourg
1
Albania
1
Djibouti
1
Southern Africa
1
Laos
1
Canada
1
North America
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
109
Clinical Guidelines
107
Pharmacy & Technologies
40
Public Health
15
Women & Child Health
15
Key Resources
9
Toolboxes
TB
69
COVID-19
66
HIV
65
AMR
32
NTDs
29
Rapid Response
21
Pharmacy
16
Zika
12
Ebola
11
Refugee
10
Caregiver
8
Polio
6
Mental Health
3
Planetary Health
3
Cholera
2
Global Health Education
2
Natural Hazards
1
Specific Hazards
1
NCDs
1
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Techni...
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progre...
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Actio...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de ...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, b...
The document, "Sustainable Management of Radiotherapy Facilities and Equipment," by WHO and IAEA, provides guidelines for managing radiotherapy equipment and facilities to ensure effective and safe cancer treatment. It covers essential aspects like preventive and corrective maintenance, funding, inf...
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
This pocket guide offers basic information needed for the medical management of victims of radiation incidents in an easy-to-understand manner.
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis...
Handbook of COVID-19 Prevention and Treatment
recommended
Handbook of COVID-19 Prevention and Treatment, expecting to share their invaluable practical advice and references with medical staff around the world. This handbook compared and analyzed the experience of other experts in China, and provides good r...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recomm...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
